RxDoctor Payments DataLook up a doctor →

Megan Weaver, NP

Adult Health · Indianapolis, INNPI 1457633786

Payments from drug & device makers

$11,001in general payments, 2019–2025

Across 481 payments — averaging $22.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • Novartis$922
  • Merck$776
  • Pfizer$630
  • Gilead$528
  • Incyte Corporation$469
  • plus $7K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)38$1,005
Novartis53$922
Merck35$776
Pfizer36$630
Gilead21$528
Incyte Corporation15$469
Daiichi Sankyo Inc.18$454
E.r. Squibb & Sons, L.L.C.10$416
Sanofi14$397
Johnson & Johnson17$375
Adaptive Biotechnologies Corporation10$370
Seagen Inc.8$370
Amgen17$310
Eisai Inc.14$301
Astellas Pharma US Inc10$289
Bristol Myers Squibb11$194
AbbVie11$194
Takeda Pharmaceuticals U.S.A., Inc.8$182
Genentech USA, Inc.10$171
GSK8$143
Acrotech Biopharma Inc.6$140
Lilly USA, LLC6$123
Exelixis Inc.6$115
Jazz Pharmaceuticals Inc.5$115
Servier Pharmaceuticals LLC6$112
Blueprint Medicines Corporation4$111
Syndax Pharmaceuticals, Inc.2$110
Regeneron Healthcare Solutions, Inc.3$96
EMD Serono, Inc.4$95
Coherus Oncology, Inc.3$88
Array Biopharma Inc5$87
Genmab U.S., Inc.5$86
Beigene USA, Inc.5$84
Pharmacyclics LLC, An Abbvie Company5$82
Pharmaessentia USA Corporation5$79
Sobi, Inc4$76
Ipsen Biopharmaceuticals, Inc3$73
Pharmacosmos Therapeutics Inc.3$67
Morphosys, US Inc.3$63
Geron Corporation2$60
Puma Biotechnology, Inc.3$57
Bayer3$49
Janssen Scientific Affairs, LLC2$48
Boehringer Ingelheim2$48
AVEO Pharmaceuticals, Inc.3$42
Taiho Oncology, Inc.2$40
Caris MPI, Inc.1$35
Octapharma USA, Inc.1$35
Legend Biotech USA Inc.2$35
Mauna Kea Technologies, Inc.1$33
CTI Biopharma Corp.2$33
Tempus AI, Inc1$28
Rigel Pharmaceuticals, Inc.1$23
ADC Therapeutics America, Inc.1$20
Pharming Healthcare, Inc.1$20
Beone Medicines USA, Inc.1$19
Abbott1$19
Stemline Therapeutics Inc.1$16
Agios Pharmaceuticals, Inc.1$15
Corcept Therapeutics1$14

How this compares

$11,001 in reported general payments places this provider in the 95th percentile of 391 adult health providers in Indiana.

See all adult health providers in Indiana →

Medicare billing

Part B allowed, 2024
$26,244
Medicare patients
139
Services billed
388

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other adult health in Indianapolis

See the full list for Indiana →

Where these figures come from

Is this you, or does something look wrong? →